Addressing the heterogeneity of the ischemic stroke phenotype in human genetics research

Stroke

Volumn 33, Issue 12, 2002, Pages 2770-2774

  Meschia, James F ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cerebrovascular disorders; Genetics, medical; Phenotype; Stroke, ischemic

Indexed keywords

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; DISEASE CLASSIFICATION; FEMALE; GENETIC HETEROGENEITY; GENETIC RISK; GENOTYPE; HUMAN; MALE; PHENOTYPE; PRIORITY JOURNAL; RELIABILITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIA; AUSTRALIA; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; COMORBIDITY; CONTINENTAL POPULATION GROUPS; DATABASES, FACTUAL; EUROPE; FEMALE; GENETICS, MEDICAL; HUMANS; INFANT; MALE; MIDDLE AGED; NORTH AMERICA; PHENOTYPE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SOUTH AMERICA;

EID: 0036901345     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000035261.28528.C8     Document Type: Article

References (61)

1. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, Rankin RN, Clagett GP, Hachinski VC, Sackett DL, Thorpe KE, Meldrum HE. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis: North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1998;339: 1415-1425.
2. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med. 1999;131:492-501.
3. Chabriat H, Vahedi K, Iba-Zizen MT, Joutel A, Nibbio A, Nagy TG, Krebs MO, Julien J, Dubois B, Ducrocq X, Levasseur M, Homeyer P, Mas JL, Lyon-Caen O, Tournier Lasserve E, Bousser MG. Clinical spectrum of CADASIL: a study of 7 families: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet. 1995;346:934-939.
4. Koo B, Becker LE, Chuang S, Merante F, Robinson BH, MacGregor D, Tein I, Ho VB, McGreal DA, Whernett JR, Logan WJ. Mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes (MELAS): Clinical, radiological, pathological, and genetic observations. Ann Neurol. 1993;34:25-32.
5. Meschia JF. Subtyping in ischemic stroke genetic research. Semin Cerebrovasc Dis Stroke. 2002;2:2-13.
6. Madonna P, de Stefano V, Coppola A, Cirillo F, Cerbone AM, Orefice G, Di Minno G. Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. Stroke. 2002;33:51-56.
7. Chen F, Jian Z, Xie Q, Pu X, Xiao B, Han L. Polymorphism of human platelet alloantigen in Chinese patients with acute myocardial infarction and acute ischemic stroke. Chin Med J. 2000;113:702-705.
8. Iniesta JA, Corral J, Gonzalez-Conejero R, Diaz Ortuno A, Martinez Navarro ML, Vicente V. Role of factor XIII Val 34 Leu polymorphism in patients with migraine. Cephalalgia. 2001;21:837-841.
9. del Ser T, Bornstein B, Barba R, Cemillan C. Relationship of angiotensin converting enzyme genotype with serum triglyceride concentration in stroke patients. Neurosci Lett. 2001;316:21-24.
10. Hassan A, Ali N, Dong Y, Carter ND, Markus HS. Atrial natriuretic peptide gene G664A polymorphism and the risk of ischemic cerebrovascular disease. Neurology. 2001;57:1726-1728.
11. Myllykangas L, Polvikoski T, Sulkava R, Notkola IL, Rastas S, Verkkoniemi A, Tienari PJ, Niinisto L, Hardy J, Perez-Tur J, Kontula K, Haltia M. Association of lipoprotein lipase Ser447Ter polymorphism with brain infarction: A population-based neuropathological study. Ann Med. 2001;33:486-492.
12. MacLeod MJ, De Lange RP, Breen G, Meiklejohn D, Lemmon H, Clair DS. Lack of association between apolipoprotein E genotype and ischaemic stroke in a Scottish population. Eur J Clin Invest. 2001;31: 570-573.
13. Shimo-Nakanishi Y, Urabe T, Hattori N, Watanabe Y, Nagao T, Yokochi M, Hamamoto M, Mizuno Y. Polymorphism of the lipoprotein lipase gene and risk of atherothrombotic cerebral infarction in the Japanese. Stroke. 2001;32:1481-1486.
14. Chowdhury AH, Yokoyama T, Kokubo Y, Zaman MM, Haque A, Tanaka H. Apolipoprotein E genetic polymorphism and stroke subtypes in a Bangladeshi hospital-based study. J Epidemiol. 2001;11:131-138.
15. Baker RI, Eikelboom J, Lofthouse E, Staples N, Afshar-Kharghan V, Lopez JA, Shen Y, Berndt MC, Hankey G. Platelet glycoprotein Ibα Kozak polymorphism is associated with an increased risk of ischemic stroke. Blood. 2001;98:36-40.
16. Finnila S, Hassinen IE, Majamaa K. Phylogenetic analysis of mitochondrial DNA in patients with an occipital stroke: Evaluation of mutations by using sequence data on the entire coding region. Mutat Res. 2001;458:31-39.
17. Gemmati D, Serino ML, Ongaro A, Tognazzo S, Moratelli S, Resca R, Moretti M, Scapoli GL. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases. Am J Hematol. 2001;67:183-188.
18. Topic E, Timundic AM, Ttefanovic M, Demarin V, Vukovic V, Loyrencic-Huzjan A, Zuntar I. Polymorphism of apoprotein E (APOE), methylenetetrahydrofolate reductase (MTHFR) and paraoxonase (PONI) genes in patients with cerebrovascular disease. Clin Chem Lab Med. 2001;39:346-350.
19. Sethi AA, Tybjaerg-Hansen A, Gronholdt ML, Steffensen R, Schnohr P, Nordestgaard BG. Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease: Six case-control studies from the Copenhagen City Heart Study. Ann Intern Med. 2001;134:941-954.
20. Akar N, Duman T, Akar E, Deda G, Sipahi T. The α2 gene alleles of the platelet collagen receptor integrin α2β1 in Turkish children with cerebral infarct. Thromb Res. 2001;102:121-123.
21. Akar N, Akar E, Ozel D, Deda G, Sipahi T. Common mutations at the homocysteine metabolism pathway and pediatric stroke. Thromb Res. 2001;102:115-120.
22. Tachikawa H, Tsuda M, Onoe K, Ueno M, Takagi S, Shinohara Y. α-1-Antichymotrypsin gene A1252G variant (ACT Isehara-1) is associated with a lacunar type of ischemic cerebrovascular disease. J Hum Genet. 2001;46:45-47.
23. Morrison AC, Doris PA, Folsom AR, Nielo FJ, Boerwinkle E, for the Atherosclerosis Risk in Communities Study. G-protein β3 subunit and α-adducin polymorphisms and risk of subclinical and clinical stroke. Stroke. 2001;32:822-829.
24. Hou L, Osei-Hyiaman D, Yu H, Ren Z, Zhang Z, Wang B, Harada S. Association of a 27-bp repeat polymorphism in ecNOS gene with ischemic stroke in Chinese patients. Neurology. 2001;56:490-496.
25. Frossard PM, Malloy MJ, Lestringant GG, Kane JP. Haplotypes of the human renin gene associated with essential hypertension and stroke. J Hum Hypertens. 2001;15:49-55.
26. Frikke-Schmidt R, Nordestgaard BG, Thudium D, Moes Gronholdt ML, Tybjaerg-Hansen A. APOE genotype predicts AD and other dementia but not ischemic cerebrovascular disease. Neurology. 2001;56:194-200.
27. Frank MB, Reiner AP, Schwartz SM, Kumar PN, Pearce RM, Arbogast PG, Longstreth WT Jr, Rosendaal FR, Psaty BM, Siscovick DS. The Kozak sequence polymorphism of platelet glycoprotein Ibα and risk of nonfatal myocardial infarction and nonfatal stroke in young women. Blood. 2001;97:875-879.
28. Lin JJ, Yueh KC, Lin GY, Chang DC, Chang CY, Shieh HL, Harn HJ. Lack of association between angiotensin 1-converting enzyme gene deletion polymorphism and cerebrovascular disease in Taiwanese. J Formos Med Assoc. 2000;99:895-901.
29. Ito D, Mumm M, Tanahashi N. Sato H, Sonoda A, Saito I, Watanabe K, Fukuuchi Y. Polymorphism in the promoter of lipopolysaccharide receptor CD14 and ischemic cerebrovascular disease. Stroke. 2000;31: 2661-2664.
30. Johnston JM, Nazar-Stewart V, Kelsey SF, Kamboh MI, Ganguli M. Relationships between cerebrovascular events, APOE polymorphism and Alzheimer's disease in a community sample. Neuroepidemiology. 2000; 19:320-326.
31. Vila N, Obach V, Revilta M, Oliva R, Chamorro A. α(1)Antichymotrypsin gene polymorphism in patients with stroke. Stroke. 2000;31:2103-2105.
32. Carlsson M, Orho-Melander M, Hedenbro J, Almgren P, Groop LC. The T 54 allele of the intestinal fatty acid-binding protein 2 is associated with a parental history of stroke. J Clin Endocrinol Metab. 2000;85: 2801-2804.
33. Elbaz A, Poirier O, Moulin T, Chedru F, Cambien F, Amarenco P. Association between the Glu298Asp polymorphism in the endothelial constitutive nitric oxide synthase gene and brain infarction: The GENIC Investigators. Stroke. 2000;31:1634-1639.
34. Reiner AP, Kumar PN, Schwartz SM, Longstreth WT Jr, Pearce RM, Rosendaal FR, Psaty BM, Siscovick DS. Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke. 2000; 31:1628-1633.
35. Catto AJ, McCormack LJ, Mansfield MW, Carter AM, Barnford JM, Robinson P, Grant PJ. Apolipoprotein E polymorphism in cerebravascular disease. Acta Neurol Scand. 2000;101:399-404.
36. Kokubo Y, Chowdhury AH, Date C, Yokoyama T, Sobue H, Tanaka H. Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population. Stroke. 2000;31:1299-1306.
37. Wittrup HH, Nordestgaard BG, Sillesen H, Schnohr P, Tybjaerg-Hansen A. A common mutation in lipoprotein lipase confers a 2-fold increase in risk of ischemic cerebrovasular disease in women but not in men. Circulation. 2000;101:2393-2397.
38. Ito D, Murata M, Watanabe K, Yoshida T, Saito I, Tanahashi N, Fukuuchi Y. C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population. Stroke. 2000; 31:936-939.
39. Voetsch B, Damasceno BP, Camargo EC, Massaro A, Bacheschi LA, Scarf M, Annichino-Bizzacchi JM, Arruda VR. Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults. Thromb Haemost. 2000;83:229-233.
40. Imai Y, Morita H, Kurihara H, Sugiyama T, Karo N, Ebihara A, Hamada C, Kurihara Y, Shindo T, Oh-Hashi Y, Yazaki Y. Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases. Atherosclerosis. 2000;149:435-442.
41. Oguchi S, Ito D, Murata M, Yoshida T, Tanahashi N, Fukuuchi Y, Ikeda Y, Watanabe K. Genotype distribution of the 46C/T polymorphism of coagulation factor XII in the Japanese population: Absence of its association with ischemic cerebrovascular disease. Thromb Haemost. 2000; 83:178-179, Letter.
42. Sonoda A, Murata M, Ito D, Tanahashi N, Ohta A, Tada Y, Takeshita E, Yoshida T, Saito I, Yamamoto M, Ikeda Y, Fukuuchi Y, Watanabe K. Association between platelet glycoprotein lba genotype and ischemic cerebrovascular disease. Stroke. 2000;31:493-497.
43. Kato N, Morita H, Sugiyama T, Kurihara H, Tsubaki S, Nabika T, Kitamura K, Yamori Y, Yazaki Y. Evaluation of the poly(ADP-ribose) polymerase gene in human stroke. Atherosclerosis. 2000;148:345-352.
44. Peterlin B, Milanez T, Kobal J, Peterlin-Potisk K, Petrovic D, Grad A, Pogacnik T. DD genotype of the angiotensin-converting enzyme gene and stroke in Slovenian population. Pflugers Arch. 2000;439(suppl): R38-R39.
45. Elbaz A, Poirier O, Canaple S, Chedru F, Camblen F, Amarenco P. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. Blood. 2000;95:586-591.
46. Roest M, van der Schouw YT, Banga JD, Tempelman MJ, de Groot PG, Sixma JJ, Grobbee DE. Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women. Circulation. 2000;101:67-70.
47. Special report from the National Institute of Neurological Disorders and Stroke: Classification of cerebrovascular diseases III. Stroke. 1990;21: 637-676.
48. Foulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB. The Stroke Data Bank: Design, methods, and baseline characteristics. Stroke. 1988;19: 547-554.
49. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521-1526.
50. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gotzsche PC, Lang T, for the CONSORT Group (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med. 2001; 134:663-694.
51. Moher D, Schulz KF, Altman DG. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group mndomised trials. Lancet. 2001;357:1191-1194.
52. Moher D, Fortin P, Jadad AR, Juni P, Klassen T, Le Lorier J, Liberati A, Linde K, Penna A. Completeness of reporting of trials published in languages other than English: Implications for conduct and reporting of systematic reviews. Lancet. 1996;347:363-366.
53. Schulz KF, Grimes DA. Blinding in randomised trials: Hiding who got what. Lancet. 2002;359:696-700.
54. Brookes ST, Whitley E, Peters TJ, Mulheran PA, Egger M, Davey Smith G. Subgroup analyses in randomised controlled trials: Quantifying the risks of false-positives and false-negatives. Health Technol Assess Rep. 2001;5:1-56.
55. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III. Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial: TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
56. Gordon DL, Bendixen BH, Adams HP Jr, Clarke W, Kappelle LJ, Woolson RF. Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: Implications for clinical trials: The TOAST Investigators. Neurology. 1993;43:1021-1027.
57. Lindley RI, Warlow CP, Wardlaw JM, Dennis MS, Slattery J, Sandercock PA. Interobserver reliability of a clinical classification of acute cerebral infarction. Stroke. 1993;24:1801-1804.
58. Thygesen K. Trial end-point committees: The king-pin of good clinical practice. Eur Heart J. 1999;20:708-709.
59. Walter SD, Cook DJ, Guyatt GH, King D, Troyan S, for the Canadian Lung Oncology Group. Outcome assessment for clinical trials: How many adjudicators do we need? Control Clin Trials. 1997;18:27-42.
60. Anderson RN, Minino AM, Hoyert DL, Rosenberg HM. Comparability of cause of death between ICD-9 and ICD-10: Preliminary estimates. Natl Vital Stat Rep. 2001;49:1-32.
61. Goldstein LB. Accuracy of ICD-9-CM coding for the identification of patients with ischemic stroke: EFfect of modifier codes. Stroke. 1998;29:1602-1604.